FDA Inspection 1042670 — Pure Source, LLC

Pure Source, LLC — FEI 3002754162

The FDA completed an inspection of Pure Source, LLC on Mar 1, 2018 in Doral, FL. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Mar 1, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Doral, FL (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
117721 CFR 211.63Equipment Design, Size and Location
202721 CFR 211.192Investigations of discrepancies, failures
358321 CFR 211.110(a)Written in-process control procedures
361321 CFR 211.160(b)(4)Establishment of calibration procedures
431421 CFR 211.84(d)(2)Reports of Analysis (Components)
435721 CFR 211.166(a)Results not used for expiration dates, storage cond.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.